Page last updated: 2024-11-04

rolipram and Idiopathic Pulmonary Fibrosis

rolipram has been researched along with Idiopathic Pulmonary Fibrosis in 2 studies

Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

Research Excerpts

ExcerptRelevanceReference
"Rolipram (0."1.35Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats. ( Hou, YH; Pan, JB; Zhang, GJ, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maher, TM1
Wells, AU1
Pan, JB1
Hou, YH1
Zhang, GJ1

Other Studies

2 other studies available for rolipram and Idiopathic Pulmonary Fibrosis

ArticleYear
Lost in translation; from animal models of pulmonary fibrosis to human disease.
    Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:7

    Topics: Animals; Bleomycin; Cyclic AMP; Cytokines; Disease Models, Animal; Humans; Idiopathic Pulmonary Fibr

2009
Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats.
    Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:7

    Topics: Animals; Bleomycin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Disease Mod

2009